Performance Decomposition
AI Analysis
1Y
3Y
5Y
Market capitalization of NHS increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of NHS in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is NHS currently overvalued or undervalued?
Neuberger Berman High Yield Strategies Fund (NHS) is now in the Fair zone, suggesting that its current forward PE ratio of NaN is considered Fairly compared with the five-year average of . The fair price of Neuberger Berman High Yield Strategies Fund (NHS) is between to according to relative valuation methord.
What is Neuberger Berman High Yield Strategies Fund (NHS) fair value?
NHS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Neuberger Berman High Yield Strategies Fund (NHS) is between to according to relative valuation methord.
How does NHS's valuation metrics compare to the industry average?
The average P/S ratio for NHS's competitors is , providing a benchmark for relative valuation. Neuberger Berman High Yield Strategies Fund Corp (NHS) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Neuberger Berman High Yield Strategies Fund (NHS) as of Jan 18 2026?
As of Jan 18 2026, Neuberger Berman High Yield Strategies Fund (NHS) has a P/B ratio of NaN. This indicates that the market values NHS at NaN times its book value.
What is the current FCF Yield for Neuberger Berman High Yield Strategies Fund (NHS) as of Jan 18 2026?
As of Jan 18 2026, Neuberger Berman High Yield Strategies Fund (NHS) has a FCF Yield of NaN%. This means that for every dollar of Neuberger Berman High Yield Strategies Fund’s market capitalization, the company generates NaN cents in free cash flow.
What is the current Forward P/E ratio for Neuberger Berman High Yield Strategies Fund (NHS) as of Jan 18 2026?
As of Jan 18 2026, Neuberger Berman High Yield Strategies Fund (NHS) has a Forward P/E ratio of NaN. This means the market is willing to pay $NaN for every dollar of Neuberger Berman High Yield Strategies Fund’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Neuberger Berman High Yield Strategies Fund (NHS) as of Jan 18 2026?
As of Jan 18 2026, Neuberger Berman High Yield Strategies Fund (NHS) has a Forward P/S ratio of NaN. This means the market is valuing NHS at $NaN for every dollar of expected revenue over the next 12 months.